We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

5 hedge funds and large institutions have $73.2K invested in BioCardia, Inc. Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $59.9K → $73.2K (+$13.3K)

0% more funds holding

Funds holding: 5 → 5 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$9.11K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$923
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$30.3K +$9.11K +10,412 +51%
Osaic Holdings
2
Osaic Holdings
Arizona
$25.4K – – –
G
3
GenTrust
Florida
$12.7K – – –
Bank of America
4
Bank of America
North Carolina
$4.76K – – –
UBS Group
5
UBS Group
Switzerland
$37 -$923 -1,055 -96%

BCDAW Hedge Fund Activity: Q1 2023 in Review

5 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q1 2023, worth a combined $73.2K — up 22% from $59.9K a quarter earlier.

Fund positioning in BCDAW was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $9.11K. The largest seller was UBS Group, cutting an estimated $923.

  • 5 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $73.2K of BioCardia, Inc. Warrant stock for Q1 2023, up 22% quarter-over-quarter.
  • 0 funds opened new BioCardia, Inc. Warrant positions in Q1 2023 and 0 closed out.
  • The largest BioCardia, Inc. Warrant buyer in Q1 2023 was Citadel Advisors, an estimated $9.11K added.
  • The largest BioCardia, Inc. Warrant seller in Q1 2023 was UBS Group, an estimated $923 sold.

Based on aggregated 13F filings for Q1 2023.